FDG PET in Head and Neck Cancer

American Journal of Roentgenology

Volumn 169, Issue 6, 1997, Pages 1663-1669

  Keyes Jr , John W ^a   Watson Jr , Nat E ^a   Williams III, Daniel W ^a   Greven, Kathryn M ^a   McGuirt, W Frederick ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORINE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; METASTASIS; MIDDLE AGED; NEOPLASM; SALIVARY GLAND TUMOR; SCINTISCANNING; SECOND CANCER;

ADULT; AGED; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NEOPLASMS, UNKNOWN PRIMARY; RADIOPHARMACEUTICALS; SALIVARY GLAND NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031299638     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.169.6.9393187     Document Type: Article

References (26)

1. DiChiro G. Positron emission tomography using 18-F fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-371
2. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991;32:623-648
3. Spence AM, Graham MM, Muzi M, et al. Deoxyglucose lumped constant estimated in a transplanted rat astrocytic glioma by the hexose utilization index. J Cereb Blood Flow Metab 1990;10:190-198
4. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-288
5. Reisser CL, Haberkorn U, Strauss LG. The relevance of positron emission tomography for the diagnoses and treatment of head and neck tumors. J Otolaryngol 1993;22:231-238
6. Braams JW, Pruim J, Freling NJM, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-216
7. Keyes JW Jr, Harkness BA, Graven KM, William DW III, Watson NE Jr, McGuirt WF. Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994;192:99-102
8. Rege S, Moass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73:3047-3058
9. Zeitouni AG, Yamamoto YL, Black M, Gjedde A. Functional imaging of head and neck tumors using positron emission tomography. J Otolaryngol 1994;23:77-80
10. McGuirt WF, Greven KM, Keyes JW Jr, et al. Positron emission tomography in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 1995;104:274-278
11. McGuirt WF, Williams DW III, Keyes JW Jr, et al. A comparative diagnostic study of head and neck metastases using positron emission tomography. Laryngoscope 1995;105:373-375
12. Rege SD, Chaiken L, Hoh CK, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189:807-812
13. Kostakoglu L, Wong JCH, Barrington SF, Cronin BF, Dynes AM, Maisey MN. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med 1996;37:1771-1773
14. Million RR, Cassisi NJ, Mancuso AA. The unknown primary. In: Million RR, Cassisi NJ, eds. Management of head and neck cancer: a multidisciplinary approach, 2nd ed. Philadelphia: Lippincott, 1994:311-321
15. Mukherji SK, Drane WB, Mancuso AA, Parsons JT, Mendenhall WM, Stunger S. Occult primary tumors of the head and neck: detection with 2-[F-18]fluoro-2-deoxy-D-glucose SPECT. Radiology 1996;199:761-766
16. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994;74:1933-1938
17. Christensen PH, Joergensen K, Munk J. Hyperfrequency of pulmonary cancer in a population of 415 patients treated for laryngeal cancer. Laryngoscope 1987;97:612-614
18. Gluckman JL, Crissman JD, Donegan JO. Multicentric squamous cell carcinoma of the upper aerodigestive tract. Head Neck Surg 1980;3:90-96
19. Chin R Jr, Ward R, Keyes JW Jr, et al. Mediastinal staging of non-small cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995;152:2090-2096
20. Steinart HC, Hauser M, Allemann F, et al. Nonsmall cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-446
21. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490
22. 18F-fluorodeoxyglucose positron emission tomography. AJR 1997;168:417-424
23. Layfield LJ, Tan P, Glasgow BJ. Fine-needle aspiration of salivary gland lesions: comparison with frozen sections and histologic findings. Arch Pathol Lab Med 1987;111:346-353
24. Bryan RN, Miller RH, Ferreyro FL, et al. Computed tomography of the major salivary glands. AJR 1982;139:547-554
25. Freling NJM, Molenaar WM, Vermey A, et al. Malignant parotid tumors: clinical use of MR imaging and histologic correlation. Radiology 1992;185:691-696
26. Gupta NC, Frank AR, Dewan N, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-444